Corporate / M&A

Capital Markets

Financial Market Regulation

Homburger News

Share-Image Teamplate Deals-and-Cases

Homburger advised BeOne Medicines Ltd. on its redomiciliation to Switzerland

On May 27, 2025, BeOne Medicines Ltd., a global oncology company, officially completed its redomiciliation from the Cayman Islands to Basel, Switzerland, following shareholder approval on April 28, 2025. The redomiciliation to Switzerland strengthens BeOne’s presence and deepens its roots in a global biopharmaceutical hub, further enabling its growth strategy of bringing innovative medicines to patients around the world.
BeOne Medicines Ltd.&#8217;s American Depositary Shares are listed on the Nasdaq Global Select Market, each representing 13 ordinary shares of BeOne Medicines Ltd., each having a par value of USD 0.0001 per share (the “Ordinary Shares”), the Ordinary Shares are listed on The Stock Exchange of Hong Kong Limited, and the Ordinary Shares traded in Renminbi are listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange.
The Homburger team was led by David Oser (Corporate / M&amp;A, Capital Markets) and included Bianca Nedwed and Kaiyan Yeo (both Corporate / M&amp;A, Capital Markets), Stefan Bindschedler and Benjamin Leisinger (Banking and Finance) as well as Stefan Oesterhelt and Juliette Buob (both Tax).

IP / IT

Competition

Temenos_web_640x140

Homburger advised Temenos on the completion of the sale of its fund administration software business to Montagu Private Equity

On June 2, 2025, Temenos announced that it has completed the sale of Multifonds, its fund administration software business, to Montagu Private Equity.
The Homburger team was led by Dieter Gericke and Daniel Häusermann (both Corporate / M&amp;A) and included Nicola Togni, Romain Hondius, Thomas Romelli, Luca Ellenberger, Miriam Oelgarth and Myriam Amman-Jerdak (all Corporate / M&amp;A), Gregor Bühler, Philippe Baumann and Kristina Martinovic (all IP / IT), Stefan Oesterhelt, Laetitia Fracheboud and Juliette Buob (all Tax) as well as Richard Stäuber and Christoph Grüninger (both Competition).

Technology and Digital Economy

Regulatory

On February 6, 2025, Temenos announced that it has reached an agreement with Montagu Private Equity for the sale of Multifonds, its fund administration software business, for a total Enterprise Value of around USD 400 m including an earn-out. Multifonds is a leading global provider of fund administration software, serving all asset classes across multiple jurisdictions and helping fund administrators, asset managers, insurance companies and pension funds achieve increased operational efficiency, whilst reducing risk.
The Homburger team is led by Dieter Gericke and Daniel Häusermann (both Corporate / M&amp;A) and included Nicola Togni, Romain Hondius, Thomas Romelli, Luca Ellenberger and Miriam Oelgarth (all Corporate / M&amp;A), Gregor Bühler, Philippe Baumann and Kristina Martinovic (all IP / IT, Technology and Digital Economy), Stefan Oesterhelt, Laetitia Fracheboud and Juliette Buob (all Tax) as well as Richard Stäuber and Christoph Grüninger (both Competition, Regulatory).

Juliette
Buob

Homburger advised BeOne Medicines Ltd. on its redomiciliation to Switzerland

Homburger advised Temenos on the completion of the sale of its fund administration software business to Montagu Private Equity

Homburger advises Temenos on the sale of Multifonds to Montagu Private Equity

Join the Team

Juliette Buob

Career

Languages

Teams

JulietteBuob

Homburger advised BeOne Medicines Ltd. on its redomiciliation to Switzerland

Homburger advised Temenos on the completion of the sale of its fund administration software business to Montagu Private Equity

Homburger advises Temenos on the sale of Multifonds to Montagu Private Equity

Join the Team

Juliette Buob

Career

Languages

Teams

Juliette
Buob